| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 1 55-60, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
GP Kalemkerian, RK Jasti, P Celano, BD Nelkin and M Mabry
Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231.
Transitions between the small cell lung cancer and the non-small cell lung cancer phenotype occur during clinical tumor progression in small cell lung cancer. We have previously developed a culture model which mimics these transitions. In our model, the insertion of the v-Ha-ras oncogene into c-myc overexpressing NCI-H82 small cell lung cancer cells induces features characteristic of non-small cell lung cancer. We now report that treatment of NCI-H82 cells with 1 microM all-trans-retinoic acid resulted in decreased cellular growth, decreased c-myc mRNA levels, and increased L-myc mRNA levels. Retinoic acid treatment prior to v-Ha-ras insertion also inhibited the typical ras-induced phenotypic transition seen in untreated NCI-H82 cells. In contrast, retinoic acid treatment of NCI-H82 ras cells after ras-induced transition to the non-small cell lung cancer phenotype did not affect cellular phenotype, nor c-myc or L-myc gene expression. These data show that all-trans-retinoic acid, a clinically relevant compound, inhibits small cell lung cancer progression in our in vitro model and alters the expression of the c-myc and L-myc oncogenes. These findings suggest mechanisms for the biological effects of retinoic acid in small cell lung cancer.
This article has been cited by other articles:
![]() |
C. Tabata, Y. Kadokawa, R. Tabata, M. Takahashi, K. Okoshi, Y. Sakai, M. Mishima, and H. Kubo All-trans-Retinoic Acid Prevents Radiation- or Bleomycin-induced Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1352 - 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hellmann, W. R. Fields, and D. J. Doolittle Gene Expression Profiling of Cultured Human Bronchial Epithelial and Lung Carcinoma Cells Toxicol. Sci., May 1, 2001; 61(1): 154 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sakaue, H. Adachi, and A. M. Jetten Post-Transcriptional Regulation of MyD118 and GADD45 in Human Lung Carcinoma Cells During 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid-Induced Apoptosis Mol. Pharmacol., April 1, 1999; 55(4): 668 - 676. [Abstract] [Full Text] |
||||
![]() |
H. Adachi, G. Preston, B. Harvat, M. I. Dawson, and A. M. Jetten Inhibition of Cell Proliferation and Induction of Apoptosis by the Retinoid AHPN in Human Lung Carcinoma Cells Am. J. Respir. Cell Mol. Biol., March 1, 1998; 18(3): 323 - 333. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |